Quarterly report pursuant to Section 13 or 15(d)

CONDENSED CONSOLIDATED BALANCE SHEETS (Unaudited)

v3.22.1
CONDENSED CONSOLIDATED BALANCE SHEETS (Unaudited) - USD ($)
$ in Thousands
Mar. 31, 2022
Dec. 31, 2021
CURRENT ASSETS    
Cash and cash equivalents $ 813 $ 2,279
Accounts receivable, net 938 1,040
Inventories, net 3,453 4,392
Prepaid expenses and other current assets 1,244 1,380
Total current assets 6,448 9,091
Property and equipment, net 138 147
Equity method investment 17,771 17,616
Right of use assets 3,318 3,485
Investment in convertible bond 23,521 26,100
Other assets 297 295
Total assets 51,493 56,734
CURRENT LIABILITIES    
Accounts payable and accrued expenses 9,718 9,189
Operating lease liabilities, current portion 738 740
Conversion feature derivative, notes payable 4,427 7,507
Other current liabilities 2,822 4,404
Revolving line of credit from related party 400 400
Warrant derivative liabilities 755 1,503
Notes payable, current portion 2,286 2,399
Notes payable to related parties 2,836 800
Convertible notes payable, net of discount 10,569 10,158
Total current liabilities 34,551 37,100
Operating lease liabilities, less current portion 3,084 3,261
Other long-term liabilities 31,507 33,173
Notes payable, less current portion 1,500 1,500
Convertible notes payable 3,150 3,150
Total liabilities 73,792 78,184
STOCKHOLDERS’ DEFICIT    
Preferred stock — par value $0.001 per share, 15,000,000 shares authorized, none issued and outstanding
Common stock — par value $0.001 per share, 250,000,000 shares authorized, shares 49,311,864 shares issued and outstanding as of March 31, 2022 and December 31, 2021 49 49
Additional paid-in capital 220,027 220,022
Accumulated other comprehensive income (loss) 433 (255)
Accumulated deficit (242,808) (241,266)
Total stockholders’ deficit (22,299) (21,450)
Total liabilities & stockholders’ deficit $ 51,493 $ 56,734